Last reviewed · How we verify

NCT07322939

Effects of Exercise With Visual Feedback in Parkinson's Disease

Recruiting now NA Last updated 27 January 2026
What this trial tests

NA trial testing Control Group in Parkinson Disease in 32 participants. Currently enrolling.

Timeline
1 December 2025
Primary endpoint
5 April 2026
5 May 2026

Quick facts

Lead sponsorHasan Kalyoncu University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment32
Start date1 December 2025
Primary completion5 April 2026
Estimated completion5 May 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hasan Kalyoncu University

Who can join

Adults 18 to 85, any sex, with Parkinson Disease or Balance Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with Parkinson's disease who apply to the Hasan Kalyoncu University Application and Research Center and meet the inclusion criteria will be included in the study. The included participants will be randomly assigned into either the intervention group or the control group using a sealed-envelope method. Both groups will undergo a standard exercise program, consisting of posture, strengthening, and balance training, under the supervision of a physiotherapist for 8 weeks, 3 days per week. In addition to this, the intervention group will receive an additional exercise program incorporating visual feedback using a laser pointer, targeting the trunk and lower extremities, also under the supervision of a physiotherapist for 8 weeks, 3 days per week.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Control Group

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Hasan Kalyoncu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07322939.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing